HIV‐1 integrase inhibitors: 2005–2006 update
- 2 November 2007
- journal article
- review article
- Published by Wiley in Medicinal Research Reviews
- Vol. 28 (1) , 118-154
- https://doi.org/10.1002/med.20116
Abstract
HIV‐1 integrase (IN) catalyzes the integration of proviral DNA into the host genome, an essential step for viral replication. Inhibition of IN catalytic activity provides an attractive strategy for antiretroviral drug design. Currently two IN inhibitors, MK‐0518 and GS‐9137, are in advanced stages of human clinical trials. The IN inhibitors in clinical evaluation demonstrate excellent antiretroviral efficacy alone or in combination regimens as compared to previously used clinical antiretroviral agents in naive and treatment‐experienced HIV‐1 infected patients. However, the emergence of viral strains resistant to clinically studied IN inhibitors and the dynamic nature of the HIV‐1 genome demand a continued effort toward the discovery of novel inhibitors to keep a therapeutic advantage over the virus. Continued efforts in the field have resulted in the discovery of compounds from diverse chemical classes. In this review, we provide a comprehensive report of all IN inhibitors discovered in the years 2005 and 2006. © 2007 Wiley Periodicals, Inc. Med Res Rev, 28, No. 1, 118–154, 2008Keywords
This publication has 109 references indexed in Scilit:
- An approach to the stereo-controlled synthesis of polycyclic derivatives of l-4-thiazolidinecarboxylic acid active against HIV-1 integraseEuropean Journal of Medicinal Chemistry, 2006
- Dihydroxythiophenes Are Novel Potent Inhibitors of Human Immunodeficiency Virus Integrase with a Diketo Acid-Like PharmacophoreJournal of Virology, 2006
- Discovery of a small-molecule HIV-1 integrase inhibitor-binding siteProceedings of the National Academy of Sciences, 2006
- Molecular dynamics studies of the full-length integrase–DNA complexBiochemical and Biophysical Research Communications, 2005
- Enzymology of a carbonyl reduction clearance pathway for the HIV integrase inhibitor, S-1360: role of human liver cytosolic aldo-keto reductasesChemico-Biological Interactions, 2004
- Synthesis of styrylbenzofuran derivatives as styrylquinoline analogues for HIV-1 integrase inhibitorIl Farmaco, 2003
- Isolation, structure, and HIV-1-integrase inhibitory activity of structurally diverse fungal metabolitesJournal of Industrial Microbiology & Biotechnology, 2003
- A Novel Short Peptide is a Specific Inhibitor of the Human Immunodeficiency Virus Type 1 IntegraseJournal of Molecular Biology, 2002
- Staurosporine, a potent inhibitor of phospholipidCa++dependent protein kinaseBiochemical and Biophysical Research Communications, 1986
- Staurosporine, a potent platelet aggregation inhibitor from a Streptomyces species.Agricultural and Biological Chemistry, 1986